ANTIBODY-MEDIATED REJECTION

Clinical trials for ANTIBODY-MEDIATED REJECTION explained in plain language.

Never miss a new study

Get alerted when new ANTIBODY-MEDIATED REJECTION trials appear

Sign up with your email to follow new studies for ANTIBODY-MEDIATED REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

Drug combo battle: can extra medication save failing kidney transplants?

Disease control Completed

This study tested whether adding the drug bortezomib to standard treatment helps control rejection in kidney transplant patients. Twenty patients whose bodies were attacking their new kidneys were split into two groups: one got standard care, the other got standard care plus bort…

Matched conditions: ANTIBODY-MEDIATED REJECTION

Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

ANTIBODY-MEDIATED REJECTION

Get alerted when new ANTIBODY-MEDIATED REJECTION trials appear

Drug combo battle: can extra medication save failing kidney transplants?